semaglutide shortage update Novo Nordisk's officially concludes in the US, spelling major threat for weight loss drug compounders semaglutide shortage over An update

Should you microdose a GLP-1

BBB profile The Better Business Bureau gives Belle Health an A+ rating, which is their highest rating

Less than a week later, Roche announced positive topline results from two arms of an ongoing, multi-part, phase I clinical trial for CT-996, an investigational, once-daily, oral GLP-1 receptor agonist being developed for the treatment of both Type 2 diabetes and obesity

With the EI-FLEX Pro, biopharma labs can now use single-molecule FRET (smFRET) to distinguish individual conformers in solution and quantify biomolecular heterogeneity with ease

This blog explains how two main types (tirzepatide and semaglutide) differ

3 University of Ottawa Heart Institute, Ottawa, Ontario, Canada